Journal of Intensive Care Medicine最新文献

筛选
英文 中文
Comparison of Midline Venous Catheters Versus Peripherally Inserted Central Catheters for Intravenous Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 静脉治疗中线静脉导管与外周置入中心静脉导管的比较:随机对照试验的系统回顾和荟萃分析。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-09-02 DOI: 10.1177/08850666261475585
Kumail Mustafa Ali, Hafsa Ahmed, Syeda Fatima Mustafa Zaidi, Talha Khalid, Ahmed Hasan, Urooba Mughal, Ibrahim Zulfiqar Ali, Farida Khan Kakar, Muhammad Hamza, Samina Fnu, Rohin Kumar, Suraksha Rani, Tayyaba Uzair, Ahmed Mustafa Rashid
{"title":"Comparison of Midline Venous Catheters Versus Peripherally Inserted Central Catheters for Intravenous Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Kumail Mustafa Ali, Hafsa Ahmed, Syeda Fatima Mustafa Zaidi, Talha Khalid, Ahmed Hasan, Urooba Mughal, Ibrahim Zulfiqar Ali, Farida Khan Kakar, Muhammad Hamza, Samina Fnu, Rohin Kumar, Suraksha Rani, Tayyaba Uzair, Ahmed Mustafa Rashid","doi":"10.1177/08850666261475585","DOIUrl":"10.1177/08850666261475585","url":null,"abstract":"<p><p>BackgroundMidline venous catheters (MVCs) have been encouraged as alternatives to peripherally inserted central catheters (PICCs) for intermediate to long-term intravenous therapy. However, randomized controlled trials (RCTs) have reported contradictory findings regarding their comparative safety and resilience. We aim to compare MVCs and PICCs in patients receiving intravenous therapy.MethodsPubMed/MEDLINE, Embase, Scopus, and the Cochrane Central databases were searched from inception through March 2025. RCTs comparing MVCs with PICCs in both pediatric and adult population were included. Primary outcomes included total complications, premature catheter removal, and median dwell times. Secondary outcomes included leakage, infiltration, occlusion, catheter-related bloodstream infection, dislodgement, pain, thrombosis, phlebitis, internal malposition, and local infection. Data were pooled using random-effects meta-analysis and reported as risk ratios (RRs) or weighted mean differences (WMDs) with 95% confidence intervals (CIs).ResultsSeven RCTs including 910 patients (MVC: 454, PICC: 456) met the inclusion criteria. Compared with PICCs, the available RCT evidence suggests that MVCs were associated with a higher risk of overall complications (RR: 2.57; 95% CI: 1.54, 4.31; <i>p</i> = 0.0003), premature catheter removal (RR: 3.91; 95% CI: 1.85, 8.27; <i>p</i> = 0.0004), and shorter median dwell time (WMD: -2.06; 95% CI: -3.18, -0.94; <i>p</i> = 0.0003). MVCs also showed higher point estimates for infiltration (RR: 3.77; 95% CI: 1.08, 13.14; <i>p</i> = 0.04), leakage (RR: 2.91; 95% CI: 1.00, 8.50; <i>p</i> = 0.05), and occlusion (RR: 3.61; 95% CI: 2.13, 6.11; <i>p</i> < 0.00001). No significant differences were reported between the two groups for catheter-related bloodstream infection, thrombosis, phlebitis, dislodgment, internal malposition, or local infection, although the event rates were low and the confidence intervals were wide, limiting certainty. Subgroup analyses were broadly consistent across adult and pediatric populations, although some pediatric-only estimates remained imprecise.ConclusionsThe available RCT evidence suggests that MVCs are associated with a higher rate of mechanical complications and reduced catheter longevity compared with PICCs. However, low event rates and imprecise estimates limit interpretation of the non-significant findings, especially for the infection-related and thrombosis outcomes, so these results do not establish equivalence between groups and should be interpreted cautiously. Our data suggest that MVCs may be selectively used based on therapy duration, infusate characteristics, and patient-specific factors rather than as routine substitutes for PICCs. Larger randomized trials with longer follow-up are required to validate the findings.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1245-1257"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing Bronchoscopy in Pediatric Critical Care: A Cohort Analysis of Practice and Outcomes. 支气管镜检查在儿科重症监护中的特点:实践和结果的队列分析。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-09 DOI: 10.1177/08850666261438400
Melany Gaetani, Thitima Sirimontakan, Karthi Nallasamy, Norbert Chin, Katherine Reise, Briseida Mema
{"title":"Characterizing Bronchoscopy in Pediatric Critical Care: A Cohort Analysis of Practice and Outcomes.","authors":"Melany Gaetani, Thitima Sirimontakan, Karthi Nallasamy, Norbert Chin, Katherine Reise, Briseida Mema","doi":"10.1177/08850666261438400","DOIUrl":"10.1177/08850666261438400","url":null,"abstract":"<p><p>BackgroundFlexible bronchoscopy (FB) has become an essential diagnostic and therapeutic tool in pediatric intensive care units (PICUs). Despite increasing adoption, comprehensive data on FB's current use, clinical impact and safety in critically ill children, particularly those supported by extracorporeal membrane oxygenation (ECMO), remain limited. We aimed to describe the utilization, findings, microbiological yield and complications of FB in critically ill pediatric patients, including its diagnostic and therapeutic applications and associated physiologic effects.MethodsThis retrospective cohort study included all children aged 0-18 years who underwent FB in a quaternary PICU between January 2019 and December 2024. Data were abstracted from the electronic medical record and analyzed descriptively. Physiologic variables before and after bronchoscopy were compared using paired differences (Δ = post - pre).ResultsA total of 179 patients underwent 246 bronchoscopies. The median age was 61 months (IQR 17-172), and the median time from PICU admission to bronchoscopy was 4 days (IQR 1-11). All patients were mechanically ventilated, and 26% were supported with ECMO. The most frequent indications were evaluation of infection (30.3%), focal imaging abnormalities (25.0%), and surveillance bronchoscopy (15.4%). Increased airway secretions were observed in 50% of procedures. Airway plug removal (22.8%), bronchoalveolar lavage (20.7%), and Dornase alfa instillation (7.7%) were the most common interventions. Multiple findings and interventions often occurred during a single procedure. Concordance between bronchoscopic and non-bronchoscopic lavage cultures was moderate, with highest agreement for <i>Pseudomonas aeruginosa</i> (67%) and <i>Candida</i> (100%). Complications were infrequent: minor bleeding (4.9%) and transient desaturation (4.5%) were most common; no pneumothorax or mortality occurred. Physiologic parameters showed minimal change post-procedure.ConclusionsFlexible bronchoscopy is a safe and versatile diagnostic and therapeutic procedure in the PICU, including among ECMO-supported patients. The stable physiologic profile and low complication rate support its continued integration into multidisciplinary critical care practice.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1306-1314"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13719901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147638901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caring for Heart and Lung Transplant Patients. 照顾心肺移植病人。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2025-07-15 DOI: 10.1177/08850666251351592
Brigitte Hollander, Antonio Rubino, Jasvir Pamar, Florian Falter
{"title":"Caring for Heart and Lung Transplant Patients.","authors":"Brigitte Hollander, Antonio Rubino, Jasvir Pamar, Florian Falter","doi":"10.1177/08850666251351592","DOIUrl":"10.1177/08850666251351592","url":null,"abstract":"<p><p>Heart and lung transplantation are the definitive, and often the only, therapeutic option for patients with end stage cardiac or respiratory failure. Their journey through the intensive care unit often begins before the transplant operation when the global shortage of suitable donor organs makes bridging with mechanical circulatory support necessary. Once transplanted, recipients are vulnerable to a large number of complications ranging from issues arising from the operation to secondary organ failure and infection and to primary graft failure. Clinicians managing these patients need to be able to recognize these issues early and they need to have the tools to initiate treatment in a timely manner. There is no such discipline as a cardiothoracic transplant intensivist. Managing these complex patients requires a highly skilled team of individuals from different backgrounds - intensivists, surgeons, cardiologists and chest physicians as well as nurses, physiotherapists, ECMO specialists, pharmacists, dieticians and many more. They all contribute vital knowledge and skills. In order to put these to good use, however, they need to share the willingness and ability to efficiently communicate with each other. This review aims to give the general intensivist an overview over the peri-operative care of heart and lung transplant patients while also providing general principles should these patients need treatment outside a specialist intensive care unit.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1207-1217"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144637263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study. 以氯己定为基础的口服预防方案减少儿科呼吸机相关肺炎的疗效:一项前后对照研究
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-10 DOI: 10.1177/08850666261440187
Ivonne Portaccio, Orazio Genovese, Federico De Leonardis, Ilaria Vitali, Enzo Picconi, Tony Christian Morena, Federica Tosi, Audrey Marie Orr, Artiom Noto, Giorgia Spinazzola, Rita Murri, Giorgio Conti, Marco Piastra
{"title":"Efficacy of a Chlorhexidine-Based Oral Prevention Protocol in Reducing Ventilator-Associated Pneumonia in Pediatrics: A Controlled Before-After Study.","authors":"Ivonne Portaccio, Orazio Genovese, Federico De Leonardis, Ilaria Vitali, Enzo Picconi, Tony Christian Morena, Federica Tosi, Audrey Marie Orr, Artiom Noto, Giorgia Spinazzola, Rita Murri, Giorgio Conti, Marco Piastra","doi":"10.1177/08850666261440187","DOIUrl":"10.1177/08850666261440187","url":null,"abstract":"<p><p>BackgroundVentilator-associated pneumonia (VAP) remains the second most common nosocomial infection in pediatric intensive care units, yet evidence-based prevention strategies specific to children remain limited.ObjectiveTo evaluate the efficacy of a multimodal VAP prevention bundle incorporating 0.12% chlorhexidine oral care in reducing VAP incidence among mechanically ventilated pediatric patients.MethodsControlled before-after study in the Gemelli PICU (January 2016-May 2019) including 162 patients aged <18 years requiring mechanical ventilation ≥48 h: 80 historical controls (2016-2017) and 82 in the intervention group (2018-2019). The bundle comprised age-stratified oral hygiene (0.12% chlorhexidine for age >2 years, saline for younger children), head-of-bed elevation 30°-40°, biweekly microbiological surveillance, and daily weaning assessment. Primary outcome was VAP incidence using CDC/NHSN criteria.ResultsBundle implementation was associated with a 69.5% reduction in VAP incidence (20% to 6.1%, <i>P</i> = .01), decreasing from 3.3 to 1.0 VAP/100 ventilator-days. The number needed to treat was 7.2 patients. Protocol implementation reduced VAP risk (adjusted OR 0.23; 95% CI 0.07-0.81; <i>P</i> = .022). VAP-associated mortality was lower in the intervention group (0% vs 3.8% in controls). Duration of mechanical ventilation remained the strongest risk factor (OR 1.18 per day; 95% CI 1.08-1.29; <i>P</i> < .001). Pseudomonas aeruginosa was identified in 57.1% of VAP cases, with polymicrobial infections in 52.4%. All isolates remained antibiotic-susceptible.ConclusionsStructured implementation of an evidence-based VAP bundle may contribute to significant reductions in preventable VAP in pediatric intensive care. While findings are promising, the modest sample size necessitates cautious interpretation and validation through larger multicenter studies.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1275-1286"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147645650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network. 心脏重症监护病房的急性肾损伤和结果:来自重症监护心脏病学试验网络的见解。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-09 DOI: 10.1177/08850666261440201
Narayana Sarma V Singam, Mitchell Padkins, Alexander I Papolos, Benjamin B Kenigsberg, David Berg, Jason N Katz, Sean van Diepen, Alexandra K Steverson, Scott W Rose, Jeffrey Wang, Erin A Bohula, Jeong-Gun Park, David A Morrow, Gregory W Barsness, Jacob Colin Jentzer
{"title":"Acute Kidney Injury and Outcomes in the Cardiac Intensive Care Unit: Insights from the Critical Care Cardiology Trials Network.","authors":"Narayana Sarma V Singam, Mitchell Padkins, Alexander I Papolos, Benjamin B Kenigsberg, David Berg, Jason N Katz, Sean van Diepen, Alexandra K Steverson, Scott W Rose, Jeffrey Wang, Erin A Bohula, Jeong-Gun Park, David A Morrow, Gregory W Barsness, Jacob Colin Jentzer","doi":"10.1177/08850666261440201","DOIUrl":"10.1177/08850666261440201","url":null,"abstract":"<p><p>BackgroundAcute kidney injury (AKI) is associated with high morbidity and mortality in critically ill patients. Multicenter analyses describing the epidemiology of AKI in the cardiac intensive care unit (CICU) are scarce. Here, we describe the prevalence, predictors, and outcomes associated with AKI in a contemporary multicenter CICU population.MethodsThe Critical Care Cardiology Trials Network (CCCTN) is a collaboration of CICUs in North America coordinated by the TIMI Study Group (Boston, MA). We evaluated patient and hospital-level outcomes as a function of creatinine-only Kidney Disease: Improving Global Outcomes (KDIGO) AKI stage within the CCCTN registry. Logistic regression was used to assess associations with in-hospital mortality.ResultsAmong 21 603 admissions, the overall prevalence of AKI was 23.7%, which was composed of KDIGO stage 1: 12.7%, stage 2: 1.7%, and stage 3: 9.2%. A higher prevalence and severity of AKI were seen in patients with baseline kidney disease, hypertension, or diabetes and in admissions with heart failure, cardiogenic shock, and cardiac arrest (<i>P</i> < .001 for all). There was a stepwise increase in hospital mortality across AKI stages (stage 1: 23%, stage 2: 39%, stage 3: 42%; <i>P</i> < .0001). The increased risk of death associated with progressive AKI stage persisted after multivariate adjustment (adjusted OR: stage 1: 2.1, stage 2: 3.7, stage 3: 3.4).ConclusionsAKI occurs in 1 in 4 admissions to the CICU, and a higher AKI stage is incrementally associated with in-hospital mortality, highlighting a need to develop strategies to mitigate AKI and its complications.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1266-1274"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147638948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remimazolam Versus Midazolam for Sedation in Mechanically Ventilated Patients with Severe Pneumonia: A Randomized Controlled Trial. 雷马唑仑与咪达唑仑在机械通气重症肺炎患者中的镇静作用:一项随机对照试验。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-07-02 DOI: 10.1177/08850666261466236
Haobo Kong, Jingjing Pan, Min Liang, Shufeng Yu, Xuehui Fang Xuehui
{"title":"Remimazolam Versus Midazolam for Sedation in Mechanically Ventilated Patients with Severe Pneumonia: A Randomized Controlled Trial.","authors":"Haobo Kong, Jingjing Pan, Min Liang, Shufeng Yu, Xuehui Fang Xuehui","doi":"10.1177/08850666261466236","DOIUrl":"10.1177/08850666261466236","url":null,"abstract":"<p><p>PurposePatients with severe pneumonia in the intensive care unit often require mechanical ventilation and sedation. Midazolam, a common sedative, is limited by prolonged sedation and accumulation. Remimazolam besylate, a novel ultra-short-acting benzodiazepine, offers efficacy and safety. This study compared remimazolam and midazolam for sedation in mechanically ventilated patients with severe pneumonia.MethodsThis single-center, prospective, randomized controlled trial enrolled 68 adults with severe pneumonia requiring invasive mechanical ventilation, targeting a Richmond Agitation-Sedation Scale (RASS) score of -3 to 0. Patients were randomized 1:1 to receive either remimazolam (initial dose 0.2 mg/kg/h) or midazolam (initial dose 0.02 mg/kg/h), all receiving remifentanil for analgesia. The primary outcome was the proportion of time spent within the target RASS range without rescue sedation during the first 72 h after randomization. Secondary outcomes included hemodynamic parameters, oxygen saturation, duration of mechanical ventilation, ventilator-free days at day 28 +(VFD-28), and 28-day mortality.ResultsBaseline characteristics were comparable, and the median percentage of time within the target RASS range was 100% (p = 0.989) for both groups. Rescue sedation was required in 11.8% of the remimazolam group and 17.6% of the midazolam group (p = 0.734). No significant differences were observed in mean arterial pressure, heart rate, oxygen saturation, duration of mechanical ventilation, ventilator-free days at day 28, or the incidence of hypotension or bradycardia. The 28-day mortality rates were 50% in the remimazolam and 29.4% in the midazolam groups (p = 0.068).ConclusionRemimazolam provided sedation efficacy and safety comparable to midazolam in mechanically ventilated patients with severe pneumonia, with similar hemodynamic stability and no increase in adverse events, suggesting that it may be a feasible alternative for sedation in mechanically ventilated patients with severe pneumonia.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1258-1265"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148376020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes. 危重病人使用氯胺酮:对抑郁症状和血流动力学改变的见解
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-16 DOI: 10.1177/08850666261438474
Vrutti Patel, Saurabh Sujanyal, Lekhya Raavi, Sophia G Blumenfeld, Faiz Saleem, Said Bateh, Abby Hanson, Anek Jena, Shahin Isha, Katie L Kunze, Patrick W Johnson, Katheleen A Rottman Pietrzak, Michelle M Ojard, Ivan A Huespe, Sadia Z Shah, Pablo Moreno Franco, Michael A Edwards, Mohit Chauhan, Devang Sanghavi, Shapiro Anna
{"title":"Ketamine Use in Critically Ill Patients: Insights into Depressive Symptoms and Hemodynamic Changes.","authors":"Vrutti Patel, Saurabh Sujanyal, Lekhya Raavi, Sophia G Blumenfeld, Faiz Saleem, Said Bateh, Abby Hanson, Anek Jena, Shahin Isha, Katie L Kunze, Patrick W Johnson, Katheleen A Rottman Pietrzak, Michelle M Ojard, Ivan A Huespe, Sadia Z Shah, Pablo Moreno Franco, Michael A Edwards, Mohit Chauhan, Devang Sanghavi, Shapiro Anna","doi":"10.1177/08850666261438474","DOIUrl":"10.1177/08850666261438474","url":null,"abstract":"<p><p>BackgroundKetamine has demonstrated efficacy in treatment-resistant depression, primarily in psychiatric or outpatient populations. Its use in ICU patients remains underexplored, with limited data beyond case reports and small series. This study evaluated the association between subanesthetic ketamine infusions and improvement in depressive symptoms and hemodynamic changes in ICU patients.MethodsWe conducted a retrospective study of adults admitted to the ICU who received IV ketamine (0.3-0.75 mg/kg over 40 min on three consecutive days) for depressive symptoms. Changes in depressive symptoms were assessed using routine clinical documentation by physicians, nurses, and occupational and physical therapists. Hemodynamic parameters (blood pressure and heart rate) were recorded before and up to 120 min after infusion. The primary outcome was to evaluate depressive symptoms while the secondary outcome was to assess hemodynamic changes post transfusion.ResultsThirty-four patients met criteria, including 18 solid organ transplant recipients. Median age was 59 years; 61.8% were male. Ketamine was associated with improvement in apparent sadness (90.0% vs 52.2%, <i>P</i> < .05) and reported sadness (95.0% vs 59.1%, <i>P</i> < .05). In transplant recipients, improvement in apparent sadness remained significant (80.0% vs 41.7%, <i>P</i> < .05). Hemodynamic parameters remained stable; heart rate increased transiently at 15-30 min post-infusion, returning to baseline by 60-90 min. Adverse effects observed were anxiety (12.5%), restlessness and/or agitation (10.4%), and dissociation (8.16%).ConclusionSubanesthetic ketamine improved specific depressive symptoms in critically ill ICU patients without significant hemodynamic instability. These findings support its potential as a rapid-acting antidepressant in the ICU, warranting further prospective trials.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1287-1296"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147690585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dexmedetomidine Use and Reduced In-hospital Mortality in ICU Patients with Delirium: A Retrospective Study Based on Two Observational Cohorts. 右美托咪定使用和降低ICU谵妄患者住院死亡率:一项基于两个观察性队列的回顾性研究。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2026-04-15 DOI: 10.1177/08850666261440805
Lizhi Fu, Sai Zhou, Huiping Liu, Wenming Song, Huan Chang, Gong Chen
{"title":"Dexmedetomidine Use and Reduced In-hospital Mortality in ICU Patients with Delirium: A Retrospective Study Based on Two Observational Cohorts.","authors":"Lizhi Fu, Sai Zhou, Huiping Liu, Wenming Song, Huan Chang, Gong Chen","doi":"10.1177/08850666261440805","DOIUrl":"10.1177/08850666261440805","url":null,"abstract":"<p><p>ObjectiveDexmedetomidine has been reported to reduce the emergence and persistence of delirium among critically ill patients, but whether it has a survival benefit in these delirium patients remains unclear. The current study aimed to investigate the link between the use of dexmedetomidine during intensive care units (ICU) admission and mortality outcomes in critically ill individuals with delirium.Materials and MethodsData from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) and the eICU Collaborative Research Database (eICU-CRD) were used to conduct this retrospective cohort study. Adult ICU patients experiencing delirium were included. Exposure was defined as the use of dexmedetomidine during ICU stay. Covariates included demographics, clinical variables, illness severity scores, interventions in the first 24 h, and comorbidities. Associations between dexmedetomidine use and in-hospital mortality were analyzed using generalized linear models and propensity score methods.ResultsPatients receiving dexmedetomidine had significantly lower in-hospital mortality rates compared to those not treated, with 17.55% versus 32.67% in the MIMIC-IV cohort and 7.41% versus 7.81% in the eICU-CRD cohort. After adjustment, dexmedetomidine use was associated with reduced in-hospital mortality (MIMIC-IV: OR 0.40, 95% CI 0.28-0.58, <i>P</i> < 0.0001; eICU-CRD: OR 0.55, 95% CI 0.46-0.67, <i>P</i> < 0.0001). Propensity score analyses confirmed these findings. Furthermore, mortality at 90 days, 180 days, and 1 year was also significantly reduced in the dexmedetomidine group.ConclusionsDexmedetomidine administration during ICU stay correlates with a reduced mortality risk in critically ill patients suffering from delirium.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1315-1322"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147690574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation and Neurological Outcomes in Cardiac Arrest - a Narrative Review of Serum Biomarker Investigations. 心脏骤停的炎症和神经预后——血清生物标志物调查的叙述性回顾。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2025-07-13 DOI: 10.1177/08850666251357536
Sergio L Angulo, Thomas W Johnson, Lilly Hutchinson, Bhagyashri Bhende, Yama Akbari, Sung-Min Cho, Imad R Khan
{"title":"Inflammation and Neurological Outcomes in Cardiac Arrest - a Narrative Review of Serum Biomarker Investigations.","authors":"Sergio L Angulo, Thomas W Johnson, Lilly Hutchinson, Bhagyashri Bhende, Yama Akbari, Sung-Min Cho, Imad R Khan","doi":"10.1177/08850666251357536","DOIUrl":"10.1177/08850666251357536","url":null,"abstract":"<p><p><b>Background:</b> Hypoxic-ischemic brain injury (HIBI) is a significant cause of disability following cardiac arrest (CA). Activation of the inflammatory cascade is central to HIBI pathophysiology and drives post-cardiac arrest syndrome (PCAS), which can induce further secondary brain injury. Although numerous studies have described this mechanism in preclinical models, translating this knowledge to therapeutic targets and neurological outcomes in humans is variable and incomplete. The impact of inflammation on the neurovascular unit, comprising neurons, astroglia, and capillary endothelium, may play a significant role in outcomes but is poorly understood in humans. <b>Objective:</b> This narrative review explores studies examining PCAS, inflammation, and neurological outcomes in adult CA and classifies them into interrelated pathomechanisms. <b>Methods:</b> We searched multiple databases using a search string constructed from core concepts, including inflammation, CA, neurovascular unit components, and neurologic outcomes. We screened abstracts published from database conception until July 2024 and excluded animal/in-vitro studies, unrelated topics, duplicates, foreign language articles, reviews/commentaries, studies without neurological outcomes, and case studies. <b>Results:</b> The biomarkers studied fit into three general domains: reperfusion-induced oxidative stress, local and systemic inflammatory response, and coagulopathy associated with endothelial injury. Numerous markers were associated with neurological outcomes after CA, but few demonstrated a strong association in multivariate analysis. Few clinical trials of therapies for CA have studied impacts on the inflammatory cascade or have targeted inflammatory components. Associations between inflammation reduction and neurological outcomes are variable. However, various limitations reduce the applicability of these trials. <b>Conclusions:</b> Inflammatory mechanisms in PCAS may hold the key to secondary brain injury and warrant larger, more systematic studies to establish therapeutic targets to improve neurological outcomes.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1218-1232"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral Tissue Oximetry Monitoring for Severe Brain Injury. 脑组织血氧仪监测重型脑损伤。
IF 2.3 3区 医学
Journal of Intensive Care Medicine Pub Date : 2026-12-01 Epub Date: 2025-07-16 DOI: 10.1177/08850666251357487
Sebastián Vásquez-García, Andrés M Rubiano, Kiwon Lee
{"title":"Cerebral Tissue Oximetry Monitoring for Severe Brain Injury.","authors":"Sebastián Vásquez-García, Andrés M Rubiano, Kiwon Lee","doi":"10.1177/08850666251357487","DOIUrl":"10.1177/08850666251357487","url":null,"abstract":"<p><p>Neurocritical care management for severe brain injuries (SBI) has traditionally focused on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) monitoring and treatment to prevent brain herniation and ischemia. However, the complex pathophysiology of secondary brain injury in SBI patients involves various mechanisms, including oxygen metabolism and transport disturbances, mitochondrial dysfunction, and signaling cascade disruption. Multimodal neuromonitoring (MMN) techniques and modern high-technology resources are being utilized to detect these detrimental phenomena and guide individualized clinical management strategies. Recent and ongoing clinical trials, mainly in traumatic brain injury (TBI), aim to assess the potential benefits, safety, reproducibility, and feasibility of adding cerebral tissue oximetry monitoring (CTOM) to the common practice of ICP monitoring. This state-of-the-art review highlights the essential concepts behind CTOM in patients with SBI, particularly in TBI, and provides practice-oriented analysis and considerations for healthcare providers managing these complex patients.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"1233-1244"},"PeriodicalIF":2.3,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144642785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书